Comparisons between prosthetic vascular graft and saphenous vein graft in femoro-popliteal bypass.
10.4174/astr.2014.87.1.35
- Author:
Keun Myoung PARK
1
;
Young Wook KIM
;
Shin Seok YANG
;
Dong Ik KIM
Author Information
1. Division of Vascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. dikim@skku.edu
- Publication Type:Original Article
- Keywords:
Polytetrafluoroethylene;
Saphenous vein;
Graft;
Patency
- MeSH:
Femoral Artery;
Humans;
Ischemia;
Knee;
Peripheral Arterial Disease;
Polytetrafluoroethylene;
Risk Factors;
Saphenous Vein*;
Transplants*
- From:Annals of Surgical Treatment and Research
2014;87(1):35-40
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Infrainguinalfemoropopliteal bypass (IFPB) is recommended to peripheral arterial disease (PAD) with a long occlusion of the superficial femoral artery (SFA). The aims of our study were to determine the patency of graft materials, and identify the risk factors of graft failure. METHODS: From January 1995 to April 2011, we had performed 380 IFPBs in 351 patients, including 302 femoro-above the knee (AK) bypasses and 78 femoro-below the knee (BK) bypasses. We compare age, sex, severity of ischemia between polytetra-uoroethylene (PTFE) graft and saphenous vein (SV) graft, and evaluate patency rate rates of the two groups. RESULTS: The primary patency rates at 5 years for SV (n = 76 limbs) and PTFE grafts (n = 226 limbs) in AK were 85.2% and 64.5% (log rank = 0.03), and the secondary patency rates at 5 years for SV and PTFE grafts in AK were 88.2% and 79.0% (log rank = 0.13). The primary patency rates at 5 years for SV (n = 50 limbs) and PTFE grafts (n = 28 limbs) in BK were 63.2% and 40.0% (log rank = 0.08), and the secondary patency rates at 5 years for SV and PTFE grafts in BK were 71.6% and 55.5% (log rank = 0.18). CONCLUSION: There was no statistical significant difference in secondary patency rates between SV and PTFE in IFPB. PTFE grafts as SV grafts can be a good alternative bypass material in IFPB instead of SV grafts.
